Latest
-
New Voice Cloning Scam Has Regulators Scrambling for Solutions: The Kiplinger Letter
The Kiplinger Letter As fraudsters add voice cloning technology to their arsenal of deception, regulators are playing catch-up.
The Kiplinger Letter -
FDA Approves Zepbound, the Latest Weight-Loss Drug: The Kiplinger Letter
The Kiplinger Letter Eli Lily’s Zepbound will undercut its rivals’ pricing but still costs over $1,000 a month.
The Kiplinger Letter -
Biden’s Reelection May Be at Risk: The Kiplinger Letter
The Kiplinger Letter Biden's weakness in polls and potential impeachment may mean darker days ahead for the Dems.
The Kiplinger Letter -
More Signs of Belt-Tightening and a Slowing Economy: The Kiplinger Letter
The Kiplinger Letter Although fewer banks are tightening lending standards, more businesses and households are feeling the squeeze.
The Kiplinger Letter -
Small Businesses Hit Extra Hard by Higher Interest Rates
The Kiplinger Letter On average, small business owners are paying interest rates in the range of 9.1%, per the NFIB.
The Kiplinger Letter -
Increasingly, Red States Embrace Marijuana: The Kiplinger Letter
The Kiplinger Letter Ohio becomes the 24th state to legalize marijuana for recreational use via a voter referendum.
The Kiplinger Letter -
The Recent Uptick In Global Trade Won’t Last
The Kiplinger Letter Global trade continues to fall as economic growth around the world cools.
The Kiplinger Letter -
Consumers Have $1 Trillion More Savings Post-Pandemic: The Kiplinger Letter
The Kiplinger Letter GDP data show Americans have more savings than they did pre-pandemic.
The Kiplinger Letter -
After Weeks Without a Speaker, Congress Finally Returns to Legislating: The Kiplinger Letter
The Kiplinger Letter Major disagreements between and within Congress make it hard to reach compromises as Congress gets back to business
The Kiplinger Letter
